Literature DB >> 10998389

Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis.

S Niemann1, E Richter, S Rüsch-Gerdes, M Schlaak, U Greinert.   

Abstract

An immunocompetent patient was dually infected with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis (TB). The multidrug-resistant strain, which belongs to the W- strain/Beijing family, was first isolated after 3 months of therapy. Inappropriate treatment led to further drug resistance and unsuccessful therapy. Thus, additional infections with resistant M. tuberculosis strains should be considered when tuberculosis therapy fails.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10998389      PMCID： PMC2627962          DOI： 10.3201/eid0605.000518

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  11 in total

1.  Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis.

Authors:  A Theisen; C Reichel; S Rüsch-Gerdes; W H Haas; J K Rockstroh; U Spengler; T Sauerbruch
Journal:  Lancet       Date:  1995-06-10       Impact factor: 79.321

2.  Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.

Authors:  D L Horn; D Hewlett; W H Haas; W R Butler; C Alfalla; E Tan; A Levine; A Nayak; S M Opal
Journal:  Ann Intern Med       Date:  1994-07-15       Impact factor: 25.391

3.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York.

Authors:  A R Moss; D Alland; E Telzak; D Hewlett; V Sharp; P Chiliade; V LaBombardi; D Kabus; B Hanna; L Palumbo; K Brudney; A Weltman; K Stoeckle; K Chirgwin; M Simberkoff; S Moghazeh; W Eisner; M Lutfey; B Kreiswirth
Journal:  Int J Tuberc Lung Dis       Date:  1997-04       Impact factor: 2.373

5.  IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995.

Authors:  S Niemann; S Rüsch-Gerdes; E Richter
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

6.  Patterns of initial and acquired antituberculosis drug resistance in Karonga District, Malawi.

Authors:  J R Glynn; P A Jenkins; P E Fine; J M Pönnighaus; J A Sterne; P K Mkandwire; S Nyasulu; L Bliss; D K Warndorff
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

7.  Stability of Mycobacterium tuberculosis IS6110 restriction fragment length polymorphism patterns and spoligotypes determined by analyzing serial isolates from patients with drug-resistant tuberculosis.

Authors:  S Niemann; E Richter; S Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.

Authors:  P M Small; R W Shafer; P C Hopewell; S P Singh; M J Murphy; E Desmond; M F Sierra; G K Schoolnik
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245

9.  Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia.

Authors:  D van Soolingen; L Qian; P E de Haas; J T Douglas; H Traore; F Portaels; H Z Qing; D Enkhsaikan; P Nymadawa; J D van Embden
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  A Pablos-Méndez; M C Raviglione; A Laszlo; N Binkin; H L Rieder; F Bustreo; D L Cohn; C S Lambregts-van Weezenbeek; S J Kim; P Chaulet; P Nunn
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245
View more
  24 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Direct DNA Extraction from Mycobacterium tuberculosis Frozen Stocks as a Reculture-Independent Approach to Whole-Genome Sequencing.

Authors:  K Bjorn-Mortensen; J Zallet; T Lillebaek; A B Andersen; S Niemann; E M Rasmussen; T A Kohl
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

3.  Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.

Authors:  Francesca Meacci; Germano Orrù; Elisabetta Iona; Federico Giannoni; Claudio Piersimoni; Gianni Pozzi; Lanfranco Fattorini; Marco R Oggioni
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients.

Authors:  Isdore Chola Shamputa; Leen Rigouts; Lovet Achale Eyongeta; Nabil Abdullah El Aila; Armand van Deun; Abdul Hamid Salim; Eve Willery; Camille Locht; Philip Supply; Françoise Portaels
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.

Authors:  Annelies van Rie; Thomas C Victor; Madalene Richardson; Rabia Johnson; Gian D van der Spuy; Emma J Murray; Nulda Beyers; Nico C Gey van Pittius; Paul D van Helden; Robin M Warren
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

Review 6.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Broad-range bacterial detection and the analysis of unexplained death and critical illness.

Authors:  Simo Nikkari; Fred A Lopez; Paul W Lepp; Paul R Cieslak; Stephen Ladd-Wilson; Douglas Passaro; Richard Danila; David A Relman
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden.

Authors:  Solomon Ghebremichael; Ramona Groenheit; Alexandra Pennhag; Tuija Koivula; Emmi Andersson; Judith Bruchfeld; Sven Hoffner; Victoria Romanus; Gunilla Källenius
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

9.  Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.

Authors:  Gustavo E Velásquez; Mercedes C Becerra; Irina Y Gelmanova; Alexander D Pasechnikov; Askar Yedilbayev; Sonya S Shin; Yevgeny G Andreev; Galina Yanova; Sidney S Atwood; Carole D Mitnick; Molly F Franke; Michael L Rich; Salmaan Keshavjee
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

10.  Mixed Mycobacterium tuberculosis-Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis, Independent of Pretreatment Heteroresistance.

Authors:  Sanghyuk S Shin; Chawangwa Modongo; Yeonsoo Baik; Christopher Allender; Darrin Lemmer; Rebecca E Colman; David M Engelthaler; Robin M Warren; Nicola M Zetola
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.